XmAb22841

· Xencor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XmAb22841, covering 2025-03-26 to 2025-03-26. Get the full timeline:

Most recent: Clinical Trial Update: XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) in Treating Melanoma Prior Immune Checkpoint Inhibitor Therapy [Phase 1]

See pricing